Fabrice Larosa

Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)

Laurence Millon, Raoul Herbrecht, Frédéric Grenouillet et al. · Clinical Microbiology and Infection · 2015 · 248 citations

Early Diagnosis, Diagnostic Mycology, French Surveillance Network +6

Quantitative Polymerase Chain Reaction Detection of Circulating DNA in Serum for Early Diagnosis of Mucormycosis in Immunocompromised Patients

Laurence Millon, Fabrice Larosa, Q. Lepiller et al. · Clinical Infectious Diseases · 2013 · 235 citations · Full text

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Franck E. Nicolini, Stéphanie Dulucq, Lisa Boureau et al. · Clinical Cancer Research · 2019 · 108 citations · Full text

Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Anne Sîrvent, Nathalie Dhédin, Mauricette Michallet et al. · Biology of Blood and Marrow Transplantation · 2009 · 93 citations · Full text

Cell Therapy, Low Nonrelapse Mortality, Immunology +19

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells

Walid Warda, Fabrice Larosa, Mathieu Neto Da Rocha et al. · Cancer Research · 2018 · 87 citations